Tranquis Therapeutics is a pioneering clinical-stage biopharmaceutical company that is dedicated to revolutionizing the management of immune-mediated and mitochondrial diseases. With a focus on restoring normal cell homeostasis and function, Tranquis is developing a portfolio of small molecule drugs that have the potential to transform a broad range of CNS and non-CNS indications, starting with ALS. At Tranquis, our groundbreaking therapeutic candidates target master regulators of cell energy metabolism, such as PGC1α, to reprogram dysfunctional myeloid immune cells, including microglia and monocytes, and switch them back to a more functional state.

Through this innovative approach, we aim to restore health and improve the lives of millions worldwide. With our smart science, expertise, innovation, and capabilities, Tranquis is committed to advancing the treatment of immune-mediated and mitochondrial diseases. Our promising pipeline of drug candidates in clinical and pre-clinical development is ready to transform the landscape of disease management.

Join us at Tranquis Therapeutics for a compelling career in our exciting, collaborative, and passionate workplace—where we are driven to make a real difference in patients' lives. Please note our contact details: +1 650. 684.

8950 and info@tranquis. com. Tranquis Therapeutics, Inc.

© 2023. All Rights Reserved